Table 1.

Cytotoxicity of Recombinant Toxins Containing Human GM-CSF

Cell LineCell TypeIC50 (ng/mL) ± SD
GM-CSF–PE38KDELDT388–GM-CSF
LS174T Colon 2.2 ± 0.7  70 ± 18  
SW403 Colon 0.9 ± 0.5  15 ± 0.6 
N87 Gastric 0.45 ± 0.2  3.7 ± 0.1 
HTB-103 Gastric 9.5 ± 7.5  400 ± 300  
HL60 Promyelocytic > 100 0.4 ± 0.2 
TF-1 Erythroleukemia  22 ± 8  0.02 ± 0.01 
U937 Monocytic 9.5 ± 5.5 0.04 ± 0.02 
Cell LineCell TypeIC50 (ng/mL) ± SD
GM-CSF–PE38KDELDT388–GM-CSF
LS174T Colon 2.2 ± 0.7  70 ± 18  
SW403 Colon 0.9 ± 0.5  15 ± 0.6 
N87 Gastric 0.45 ± 0.2  3.7 ± 0.1 
HTB-103 Gastric 9.5 ± 7.5  400 ± 300  
HL60 Promyelocytic > 100 0.4 ± 0.2 
TF-1 Erythroleukemia  22 ± 8  0.02 ± 0.01 
U937 Monocytic 9.5 ± 5.5 0.04 ± 0.02 

Cells were plated in 96-well plates at 1.5 × 104/well and incubated at 37°C for 24 hours. The cells were then incubated with recombinant toxins for 24 to 48 hours and [3H]-leucine for 4 to 6 hours.

Close Modal

or Create an Account

Close Modal
Close Modal